This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Meridian Bioscience, Inc., a life science company, develops, manufactures, and distributes diagnostic test kits primarily for certain gastrointestinal, viral, respiratory, and parasitic infectious diseases. The company operates through Diagnostics and Life Science segments.View VIVO key stats
Meridian Bioscience Inc - VIVO - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Meridian Bioscience Inc as a
Buy with a ratings score of B-.
Report Snippet: We rate MERIDIAN BIOSCIENCE INC (VIVO) a BUY. This is driven by several positive factors, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and expanding profit margins. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity.